Detalles de la búsqueda
1.
Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
N Engl J Med;
383(17): 1613-1623, 2020 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085860
2.
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy.
Br J Haematol;
188(2): 249-258, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385309
3.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol;
189(5): 853-859, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32064595
4.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Haematologica;
2020 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32467145
5.
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Hematol Oncol;
2020 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32816326
6.
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase ii pediatric-like gimema lal-1308 trial.
Am J Hematol;
2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284999
7.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Br J Cancer;
121(2): 150-156, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209327
8.
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Br J Haematol;
184(3): 392-396, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30338509
9.
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Haematologica;
104(2): 312-318, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190342
10.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the campus all network.
Haematologica;
2019 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879328
11.
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network.
Hematol Oncol;
37(4): 368-374, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325190
12.
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.
Br J Haematol;
181(5): 642-652, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29675955
13.
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
Br J Haematol;
178(4): 583-587, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28439887
14.
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma.
Br J Haematol;
177(4): 588-596, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419517
15.
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
Hematol Oncol;
35(4): 804-809, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27400753
16.
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Am J Hematol;
92(6): 529-535, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295527
17.
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia.
Br J Haematol;
174(4): 541-9, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27172403
18.
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
Br J Haematol;
172(3): 371-383, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26597680
19.
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
Blood;
123(14): 2139-47, 2014 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24501221
20.
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.
Blood;
123(15): 2378-88, 2014 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24550227